BioSpace News Archive

Imara Inc. announced the pricing of its previously announced underwritten public offering of shares of its common stock at a public offering price of $6.00 per share, for gross proceeds of $50 million, before underwriting discounts and commissions and offering expenses payable by the Company.

LeMaitre Vascular, Inc., a provider of peripheral vascular devices, implants and services, announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at a public offering price of $54.50 per share.

Allena Pharmaceuticals, Inc. announced that it has entered into definitive agreements with several healthcare-focused institutional and accredited investors for the purchase and sale of 21,357,744 shares of the Company’s common stock and warrants to purchase up to an aggregate of 10,678,872 shares of the Company’s common stock, at a purchase price of $1.311 per share of common stock and associated warrant, in a registered direct offering priced at-the-market under Nasdaq rules.